Pharmacodynamic Study of 131i-Labeled CA215 Antibody on an Animal Model of Estrogen-Resistant OC-3-VGH Ovarian Cancer

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2015.2517
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Antitumor Effects of a Human Dimeric Antibody Fragment 131i-Afra-Dfm5.3 in a Mouse Model for Ovarian Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Therapy of Cervical Cancer Using 131i-Labeled Nanoparticles

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

SPECT Imaging of Neuropilin Receptor Type-1 Expression With 131i-Labeled Monoclonal Antibody

International Journal of Oncology
Cancer ResearchOncology
2016English

Microbial Targeting of 99mTc-Labeled Recombinant Human -Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Apoptotic and Chemotherapeutic Properties of Iron(III)-Salophene in an Ovarian Cancer Animal Model

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2008English

Unbalanced Estrogen Metabolism in Ovarian Cancer

International Journal of Cancer
Cancer ResearchOncology
2014English

Clearance Kinetics and External Dosimetry of 131i-Labeled Murine and Humanized Monoclonal Antibody A33 in Patients With Colon Cancer: Radiation Safety Implications

Health Physics
Nuclear MedicineRadiologyMutagenesisEpidemiologyHealthImagingToxicology
2009English

Pituitary Ablation of Estrogen Receptor Expression as a Mouse Model for Ovarian Cancer

Science-Business eXchange
2014English

Ovarian Cancer Animal Models for Preclinical Studies and Development of Ovarian Cancer Drugs

JURNAL ILMU KEFARMASIAN INDONESIA
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy